Curetis N.V today announced that the Company and its subsidiary Ares Genetics GmbH will present novel products, data, and services during this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid, Spain, from April 21 - 24, 2018. Curetis and Ares Genetics can be found at booth #79, hall 10, during the conference.
The Company will provide an update on its Unyvero A30 RQ Analyzer and its first A30 RQ Application Cartridge, which are in development for expected CE-IVD marking in 2019. The A30 RQ Analyzer for low- to mid-plex testing will complement the current Unyvero A50 Analyzer for high-plex syndromic testing and expand the Unyvero Platform to a modular and flexible 'any-plex' solution for rapid diagnostics in molecular microbiology.
Additionally, Curetis and Ares Genetics will present their offerings for pharmaceutical companies in the area of antibiotic drug research and development. By combining the ARES AMR Database, ARESdb, the ARES Technology Platform with advanced bioinformatics and artificial intelligence solutions, and the Unyvero Platform for rapid diagnosis, the Company is well positioned to offer a comprehensive portfolio of services and products for the discovery, clinical development, and product lifecycle management of antimicrobial drugs.
We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device.
You can find out more and set your own preferences here.
